索拉菲尼联合TACE治疗中晚期原发性肝癌的疗效观察及对患者血清AFP、VEGF水平的影响

doi:10.11748/bjmy.issn.1006-1703.2019.04.024

PDF(3643 KB)

标记免疫分析与临床 ›› 2019, Vol. 26 ›› Issue (4) : 641-644. DOI: 10.11748/bjmy.issn.1006-1703.2019.04.024

临床研究

索拉菲尼联合TACE治疗中晚期原发性肝癌的疗效观察及对患者血清AFP、VEGF水平的影响

{{article.zuoZhe_CN}}

作者信息 +

The Curative Effect of Sorafenib Combined with TACE in the Treatment of Advanced Primary Liver Cancer and Its Influence on Serum AFP and VEGF Levels

{{article.zuoZhe_EN}}

Author information +

History +

本文亮点

HeighLight

摘要

Abstract

关键词

Key words

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用

{{article.zuoZheCn_L}}. {{article.title_cn}}. {{journal.qiKanMingCheng_CN}}. 2019, 26(4): 641-644 https://doi.org/10.11748/bjmy.issn.1006-1703.2019.04.024

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2019, 26(4): 641-644 https://doi.org/10.11748/bjmy.issn.1006-1703.2019.04.024

参考文献

原文顺序 | 文献年度倒序 | 文中引用次数倒序

参考文献

基金

版权

PDF(3643 KB)

Accesses

Citation

Detail

段落导航

Received	Revised	Published
2018-10-15	2018-12-13	2019-04-20
Issue Date
2019-05-03

选择文件类型/文献管理软件名称

选择包含的内容

本文亮点

HeighLight

摘要

Abstract

关键词

Key words

引用本文

{{custom_sec.title}}

{{custom_sec.title}}

参考文献

参考文献

{{custom_fnGroup.title_cn}}

脚注

{{custom_ack.title_cn}}

基金

版权